-
-
-
-
-
-
-
China holds roundtable with over 50 foreign pharmaceutical firms
-
-
-
-
-
-
-
Merck (MRK) Tops Q1 EPS by 20c; offers guidance
-
-
-
-
-
-
-
European Commission approves Merck's ENFLONSIA for RSV prevention in infants
-
-
-
-
-
-
-
Merck launches tender offer to acquire Terns Pharmaceuticals for $53 per share
-
-
-
-
-
-
-
TD Cowen Downgrades Terns Pharmaceuticals (TERN) to Hold
-
-
-
-
-
-
-
Merck to buy oncology firm Terns Pharmaceuticals in $6.7 billion deal
-
-
-
-
-
-
-
Merck's KEYTRUDA plus Padcev reduces bladder cancer risk in trial
-
413,448 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

